Jin-Yi Wan, PhD, is a Professor at the National Institute of TCM Constitution and Preventive Medicine at Beijing University of Chinese Medicine (BUCM). A prominent figure in metabolic pharmacology and precision medicine, Dr. Wan serves as an expert on the World Health Organization (WHO) Clinical Guidelines Committee for GLP-1 receptor agonists, where she contributes to the development of international standards for metabolic disease treatment. Her academic pedigree includes a PhD from China Pharmaceutical University and an extensive postdoctoral fellowship at the University of Chicago’s Pritzker School of Medicine, an experience that solidified her expertise in bridging traditional therapeutic frameworks with modern clinical pharmacology. Dr. Wan’s research program focuses on the prevention and management of chronic diseases through the study of Traditional Chinese Medicine (TCM) Constitution. She has served as the Principal Investigator for 10 major research initiatives, including projects funded by the National Natural Science Foundation of China.